CN102796089A - 拉米夫定中间体及拉米夫定的制备方法 - Google Patents
拉米夫定中间体及拉米夫定的制备方法 Download PDFInfo
- Publication number
- CN102796089A CN102796089A CN2012102923233A CN201210292323A CN102796089A CN 102796089 A CN102796089 A CN 102796089A CN 2012102923233 A CN2012102923233 A CN 2012102923233A CN 201210292323 A CN201210292323 A CN 201210292323A CN 102796089 A CN102796089 A CN 102796089A
- Authority
- CN
- China
- Prior art keywords
- oxathiolane
- cyt
- cytosine
- carboxylic acid
- cme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 [*+2]=C(O1)SC[C@]1Cl Chemical compound [*+2]=C(O1)SC[C@]1Cl 0.000 description 2
- XEYZAKCJAFSLGZ-JKIOLJMWSA-N CC(C)[C@H](CC[C@@H](C)C1)C1OC=O Chemical compound CC(C)[C@H](CC[C@@H](C)C1)C1OC=O XEYZAKCJAFSLGZ-JKIOLJMWSA-N 0.000 description 1
- KXKDZLRTIFHOHW-HMMZJVQESA-N CC(C)[C@H](CC[C@@H](C)C1)[C@@H]1OC(C1SC[C@H](O)O1)=O Chemical compound CC(C)[C@H](CC[C@@H](C)C1)[C@@H]1OC(C1SC[C@H](O)O1)=O KXKDZLRTIFHOHW-HMMZJVQESA-N 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
实施例 | 水量(倍数) | 产物含量(%) | 收率(%) | 折百产率(%) |
2 | 10 | 85.3 | 107.2 | 91.4 |
3 | 15 | 90.5 | 100.6 | 91.0 |
1 | 20 | 98.5 | 91.2 | 89.8 |
4 | 25 | 98.9 | 86.8 | 85.8 |
5 | 30 | 99.0 | 80.5 | 79.7 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210292323.3A CN102796089B (zh) | 2012-08-16 | 2012-08-16 | 拉米夫定中间体及拉米夫定的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210292323.3A CN102796089B (zh) | 2012-08-16 | 2012-08-16 | 拉米夫定中间体及拉米夫定的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102796089A true CN102796089A (zh) | 2012-11-28 |
CN102796089B CN102796089B (zh) | 2015-06-17 |
Family
ID=47195425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210292323.3A Active CN102796089B (zh) | 2012-08-16 | 2012-08-16 | 拉米夫定中间体及拉米夫定的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102796089B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105037340A (zh) * | 2015-07-14 | 2015-11-11 | 福建广生堂药业股份有限公司 | 一种拉米夫定关键中间体手性异构体杂质的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5654441A (en) * | 1995-09-14 | 1997-08-05 | Uniroyal Chemical Ltd./Ltee | Synthesis of 1,3-oxathiolane sulfoxide compounds |
CN1563003A (zh) * | 2004-03-17 | 2005-01-12 | 济南久创化学有限责任公司 | 拉米夫啶适合工业化的制备方法 |
CN1566112A (zh) * | 2003-07-02 | 2005-01-19 | 哈尔滨三联药业有限公司 | 拉米夫定的非对映选择性制备方法 |
WO2011045815A2 (en) * | 2009-10-14 | 2011-04-21 | Matrix Laboratories Ltd. | Process for the preparation of lamivudine and novel salts in the manufacture thereof |
WO2011095987A1 (en) * | 2010-02-03 | 2011-08-11 | Matrix Laboratories Ltd. | Novel process for the preparation of cis-nucleoside derivative |
-
2012
- 2012-08-16 CN CN201210292323.3A patent/CN102796089B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5654441A (en) * | 1995-09-14 | 1997-08-05 | Uniroyal Chemical Ltd./Ltee | Synthesis of 1,3-oxathiolane sulfoxide compounds |
CN1566112A (zh) * | 2003-07-02 | 2005-01-19 | 哈尔滨三联药业有限公司 | 拉米夫定的非对映选择性制备方法 |
CN1563003A (zh) * | 2004-03-17 | 2005-01-12 | 济南久创化学有限责任公司 | 拉米夫啶适合工业化的制备方法 |
WO2011045815A2 (en) * | 2009-10-14 | 2011-04-21 | Matrix Laboratories Ltd. | Process for the preparation of lamivudine and novel salts in the manufacture thereof |
WO2011095987A1 (en) * | 2010-02-03 | 2011-08-11 | Matrix Laboratories Ltd. | Novel process for the preparation of cis-nucleoside derivative |
Non-Patent Citations (3)
Title |
---|
DAVID C. HUMBER等: "EXPEDITIOUS PREPARATION OF (-)-2’-DEOXY-3’-THIACYTIDINE(3TC)", 《TETRAHEDRON LETTERS》 * |
GRZEGORZ DUTKIEWICZ等: "5-(4-Ammonio-2-Oxopyrimidine-1(2H)-yl)-1,3-Oxathiolane-2-Carboxylate (lamivudine acid) Semihydrate: The Six-Fold Symmetry Created by Hydrogen Bond Network", 《JOURNAL OF CHEMICAL CRYSTALLOGRAPHY》 * |
刘玮炜,等: "拉米夫定的合成和应用研究进展", 《淮海工学院学报( 自然科学版)》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105037340A (zh) * | 2015-07-14 | 2015-11-11 | 福建广生堂药业股份有限公司 | 一种拉米夫定关键中间体手性异构体杂质的制备方法 |
CN105037340B (zh) * | 2015-07-14 | 2018-08-10 | 福建广生堂药业股份有限公司 | 一种拉米夫定关键中间体手性异构体杂质的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102796089B (zh) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112552288A (zh) | 一种4-肟-5`-(2-甲基丙酰基)尿苷的制备方法 | |
CN105330609B (zh) | 一种制备lcz696的方法 | |
CN104496952B (zh) | 一种达格列净的合成方法 | |
CN103396451B (zh) | 富马酸替诺福韦二吡呋酯中间体的制备方法 | |
CN102395591B (zh) | 一种合成普拉格雷的方法 | |
CN107311861B (zh) | 一种4-甲氧基乙酰乙酸乙酯及其合成方法 | |
CN101597281B (zh) | 拉米夫定及其中间体的制备方法 | |
CN101407513A (zh) | 一种核苷类似物的合成方法 | |
CN101861320A (zh) | 制备卡培他滨以及其中所用的富含β-端基异构体的三烷基碳酸酯化合物的方法 | |
CN1137892C (zh) | N-9取代的鸟嘌呤化合物的制备 | |
CN102234269A (zh) | 拉米夫定的工业化制备方法 | |
CN102796089B (zh) | 拉米夫定中间体及拉米夫定的制备方法 | |
CN101348475B (zh) | 一种奥利司他合成方法、中间体化合物及其制备方法 | |
CN113372286B (zh) | 一步法制备1-苯基-5-巯基四氮唑的方法 | |
CN107266304B (zh) | 天然产物Salvianolic Acid F的新合成方法 | |
CN114702425A (zh) | (s)-2-氨基-(s)-3-[吡咯烷酮-2’]丙氨酸衍生物及中间体的制备方法 | |
CN111499675B (zh) | 一种磷酸氟达拉滨的合成方法 | |
CN111848535B (zh) | 一种合成1h-四氮唑乙酸的工艺 | |
CN103420882B (zh) | 一种l-蛋氨酸的制备方法 | |
CN114717280A (zh) | 一种莫诺匹拉韦的合成方法 | |
CN102633594A (zh) | 利用三苯甲基烷基醚合成三苯基氯甲烷的方法 | |
CN110204557A (zh) | 一种头孢孟多酯钠衍生物的制备方法 | |
Perkin | CXCIII.—Myricetin. Part III | |
CN102675087B (zh) | 一种新的α-酮缬氨酸钙的制备方法 | |
CN103570781A (zh) | 一种卡培他滨的工业化制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU COBEN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HANGZHOU COBEN PHARMACEUTICAL CO., LTD. ZHEJIANG INTERNATIONAL STUDIES UNIVERSITY Effective date: 20141115 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141115 Address after: 226221 Qidong City, Jiangsu Province along the River Fine Chemical Park Applicant after: Jiangsu Branch of the Pharmaceutical Chemical Co., Ltd. Applicant after: Hangzhou Coben Pharmaceutical Co., Ltd. Address before: 226221 Qidong City, Jiangsu Province along the River Fine Chemical Park Applicant before: Jiangsu Branch of the Pharmaceutical Chemical Co., Ltd. Applicant before: Hangzhou Coben Pharmaceutical Co., Ltd. Applicant before: Zhejiang International Studies University |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 226221 Shanghai Road, Binjiang fine chemical industry park, Jiangsu, China, No. 168, No. Patentee after: Jiangsu Cobain Pharmaceutical Co., Ltd. Patentee after: Hangzhou Coben Pharmaceutical Co.,Ltd. Address before: 226221 Qidong City, Jiangsu Province along the River Fine Chemical Park Patentee before: Jiangsu Coben Medical Chemical Co.,Ltd. Patentee before: Hangzhou Coben Pharmaceutical Co.,Ltd. |